Nanomedicine News

RSS

Full Data Set from Novavax RSV F Vaccine Clinical Trial Published in Journal of Infectious Disease

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the full data set from its clinical trial of the RSV F-protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in women of childbearing age (18-35 years) were published in the Journal of Infectious Disease. The Company previously announced top-line results from the trial.

From Novavax Inc. 14 Sep 2015

Celsion Provides Update on Development of GEN-1 for Ovarian and Brain Cancer

Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies for the treatment of cancer and other difficult-to-treat diseases, announced today that the Company has completed the integration of its June 2014 acquisition of EGEN, Inc. and has provided an update on its clinical development plans for GEN-1, the Company's DNA-based immunotherapy for the localized treatment of ovarian and brain cancer.

10 Sep 2015

Dosing Commences in BIND Therapeutics’ BIND-014 iNSITE 2 Trial in Patients with Four Tumor Histologies

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM, today announced that patient dosing is underway in the iNSITE 2 trial, a global, phase 2, two-stage clinical trial of BIND-014 in patients with four tumor histologies.

10 Sep 2015

Tiny ‘Nanopore’ Scanners for Early Diagnosis of Cancer Biomarkers

Using tiny “nanopore” scanners that can detect individual DNA molecules, Professor Amit Meller and colleagues are on the hunt for biological markers in cancer cells that may help clinicians diagnose colorectal and lung cancers at their earliest stages.

10 Sep 2015

Nanoporous Gold Sponge Detects Pathogens Faster

A team of researchers from University of California, Davis has proved that nucleic acids can be detected using nanoporous gold, a unique sensor coating material, in a mixture containing other biomolecules, thus beating most of the currently used detectors.

8 Sep 2015

Multiphoton Microscope Reveals How Immune Cells Engage in Coordinated Behavior to Wipe Out Flu Viruses

Much like birds fly in flocks to conserve energy, dolphins swim in pods to mate and find food, and colonies of ants create complex nests to protect their queens, immune cells engage in coordinated behavior to wipe out viruses like the flu.

7 Sep 2015

Novel Technique Helps Produce Amorphous Nanoparticles for Better Drug Efficiency

Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.

3 Sep 2015

Minomic International Jointly Wins Prestigious Eureka Prize for Outstanding Science Using its Patented Antibody

Australian prostate cancer technology company Minomic International Ltd has jointly won a prestigious Australian science prize recognising 'outstanding' science that uses its patented antibody.

3 Sep 2015

Investigational New Drug for PH1 Treatment Formulated in Proprietary Lipid Nanoparticle Technology

Dicerna Pharmaceuticals, Inc., a leading developer of RNA interference (RNAi) therapeutics, today announced the submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for DCR-PH1, the company's therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1). PH1 is a severe, rare, inherited disorder of the liver that often results in kidney failure and for which there are no approved therapies.

3 Sep 2015

Novel Nanoparticle Drug Can Minimize Impact of Sepsis and ARDS in Critically Ill Patients

Scientists at Queen’s University Belfast are developing a potential revolutionary new treatment for Sepsis and Acute Respiratory Distress Syndrome (ARDS), which are among the leading causes of death in hospitalised patients in the UK. Currently, there are no effective treatments available for these life threatening syndromes.

3 Sep 2015

Nanomedicine News

Full Data Set from Novavax RSV F Vaccine Clinical Trial Published in Journal of Infectious Disease

Celsion Provides Update on Development of GEN-1 for Ovarian and Brain Cancer

Dosing Commences in BIND Therapeutics’ BIND-014 iNSITE 2 Trial in Patients with Four Tumor Histologies

Tiny ‘Nanopore’ Scanners for Early Diagnosis of Cancer Biomarkers

Nanoporous Gold Sponge Detects Pathogens Faster

Multiphoton Microscope Reveals How Immune Cells Engage in Coordinated Behavior to Wipe Out Flu Viruses

Novel Technique Helps Produce Amorphous Nanoparticles for Better Drug Efficiency

Minomic International Jointly Wins Prestigious Eureka Prize for Outstanding Science Using its Patented Antibody

Investigational New Drug for PH1 Treatment Formulated in Proprietary Lipid Nanoparticle Technology

Novel Nanoparticle Drug Can Minimize Impact of Sepsis and ARDS in Critically Ill Patients

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting